AddressFor 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform. In return, we’ll help you build a career that you can feel passionate about. Job Description We are seeking an Assistant Technician for our Clinical Pathology Laboratory department site located in Tranent, Edinburgh area. Clinical Pathology is responsible for analysing biological samples, mostly blood and urine, taken from animals on toxicology and other regulatory studies. Training will be provided for use of our Laboratory Information Management System and working in a GLP environment. Key responsibilities include the following: Tube preparation and delivery Preparation of study files Monitoring and maintaining levels of consumable products Data transfer and archiving procedures Filing Sample processing The following are minimum requirements related to the Assistant Technician position: A NAT5/Higher or equivalent qualification in two of Maths, Chemistry and Biology Strong organisational skills with the ability to pay attention to detail Good communication skills IT literate with experience of Microsoft packages. What you can expect from us: World Class Training and a structured progression scheme Competitive salary Private Health Care Subsidized electric car purchase Pension scheme including 8% employer contribution Personal life insurance equivalent to 6 times your annual salary Employee discount scheme across hundreds of retailers Paid opportunity to volunteer for one day each year On site discounted canteen Fitness suite and fitness lessons at the work place The salary for this role is £19,774 per annum + discretionary bonus. Closing date for applications is Sunday 06 March 2022. About Safety Assessment Charles River is committed to helping our partners expedite their preclinical drug development with exceptional safety assessment services, state-of-the-art facilities and expert regulatory guidance. From individual specialty toxicology and IND enabling studies to tailored packages and total laboratory support, our deeply experienced team can design and execute programs that anticipate challenges and avoid roadblocks for a smooth, efficient journey to market. Each year approximately 120 investigational new drug (IND) programs are conducted in our Safety Assessment facilities. About Charles River Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market. With over 17,000 employees within 90 facilities in 20 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world. And in 2019, revenue increased to $2.62 billion. At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of ~85% of the drugs approved by the FDA in 2019.
